Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans

Medical Mycology

Volumn 40, Issue 1, 2002, Pages 21-26

  Chiller, T ^a,b   Farrokhshad, K ^a,b   Brummer, E ^a,b   Stevens, D A ^a,b  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colony stimulating factors; Cryptococcus neoformans; Human effector cells; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CELL KILLING; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; DRUG SCREENING; EFFECTOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL;

ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MONOCYTES; NEUTROPHILS; PYRIMIDINES; TRIAZOLES;

FILOBASIDIELLA NEOFORMANS;

EID: 0036177347     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.40.1.21.26     Document Type: Article

References (13)

1. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages
2. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes
3. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route. II. Phagocytosis and intracellular fate of Cryptococcus neoformans
4. Killing of Cryptococcus neoformans by human peripheral blood mononuclear cells stimulated in culture
5. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans
6. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils
7. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi
8. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa
9. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia
10. Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
11. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
12. Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans
13. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro